I haven't been following much for the last couple of frustrating years.
It's now heartening to see such a win for children in dire need, given that no other treatment is available from Big Pharma; and of course, it is great for us as long term holders
However, I'm not convinced that FDA approval 0f CHF and CLBP will follow on so easily... the big players, with their market-leading therapies have too much to lose on these two golden geese.
Maybe I'm cynical (and I really know bugger all); but nine years holding has taught me that counting one's goslings before they've hatched is a pretty silly exercise. The share market is a mine field
None the less, I do wish us all good fortune ... our company is on the right track!
Cheers,
Pat
MSB Price at posting:
$2.04 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)